5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.70▼ | 1.74▼ | 1.77▼ | 1.84▼ | 1.72▼ |
MA10 | 1.72▼ | 1.79▼ | 1.80▼ | 1.88▼ | 2.03▼ |
MA20 | 1.78▼ | 1.82▼ | 1.84▼ | 1.73▼ | 1.74▼ |
MA50 | 1.85▼ | 1.91▼ | 1.90▼ | 1.99▼ | 2.32▼ |
MA100 | 1.92▼ | 1.85▼ | 1.75▼ | 1.76▼ | 3.78▼ |
MA200 | 1.85▼ | 1.90▼ | 2.02▼ | 2.02▼ | 3.67▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.007▼ | -0.012▼ | -0.017▼ | 0.013▲ | 0.053▲ |
RSI | 29.950▼ | 27.254▼ | 29.230▼ | 43.286▼ | 45.050▼ |
STOCH | 2.151▼ | 24.029 | 26.032 | 47.547 | 33.763 |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -48.864 | -73.936 |
CCI | -78.188 | -157.017▼ | -211.297▼ | -27.371 | -23.068 |
Wednesday, September 24, 2025 08:36 PM
Looking back on defense contractors stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including CACI (NYSE:CACI) and its peers. Defense contractors typically require technical ...
|
Wednesday, September 03, 2025 06:00 AM
SOUTH SAN FRANCISCO, CA / ACCESS Newswire / September 3, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing innovative therapies for ...
|
Tuesday, September 02, 2025 05:59 AM
- Industry veteran brings extensive senior level leadership and expertise in biologics development, strategic partnerships, mergers and acquisitions across biotech and large pharma organizations - ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/10/25 | 1.85 | 1.88 | 1.69 | 1.70 | 32,809 |
15/10/25 | 1.80 | 1.96 | 1.80 | 1.84 | 41,970 |
14/10/25 | 1.74 | 1.88 | 1.74 | 1.81 | 42,736 |
13/10/25 | 1.96 | 1.96 | 1.88 | 1.89 | 37,450 |
10/10/25 | 2.05 | 2.13 | 1.98 | 1.98 | 51,929 |
09/10/25 | 2.03 | 2.10 | 1.97 | 2.05 | 81,470 |
08/10/25 | 1.93 | 2.04 | 1.90 | 2.03 | 102,821 |
07/10/25 | 1.87 | 1.941 | 1.78 | 1.86 | 42,027 |
06/10/25 | 1.91 | 2.09 | 1.7704 | 1.83 | 165,252 |
03/10/25 | 1.85 | 2.065 | 1.78 | 1.85 | 188,007 |
|
|
||||
|
|
||||
|
|